Article
Pharmacogenomics of anticoagulants: steps toward personal dosage
1 Jan 2009
Abstract excerpt
Warfarin and other coumarin anticoagulants are widely used clinically, but currently dosing is determined individually on the basis of patient response. There is increasing evidence that genetic factors, together with several non-genetic patient-specific factors, are important determinants of stable dose requirement for these compounds. Genotype for CYP2C9, which encodes the main cytochrome P450 enzyme that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
